Brunsmann Frank
Fachbereichsleiter Diagnose und Therapie der PRO RETINA Deutschland e.V., Bonn, Deutschland Sprecher der Patientenvertretung im Unterausschuss Qualitätssicherung des Gemeinsamen Bundesausschusses (im Sprecherteam), Berlin, Deutschland.
Z Evid Fortbild Qual Gesundhwes. 2020 Nov;156-157:100-104. doi: 10.1016/j.zefq.2020.07.003. Epub 2020 Aug 30.
The article addresses deficits in patient orientation and patient involvement in medical research from a patient's perspective and provides recommendations for their further development. Researchers often practice patient orientation as well as patient involvement in an unstructured and inconsistent manner. The decision if and how patient involvement takes place is, to a considerable extent, the researchers' responsibility. This decision should always be part of a patient-oriented alignment of the research project, which researchers pursue regardless of the existence, initiative and participation of a patient organization. Possible modes of involvement are assigned to different phases of the research process. In this article, patient orientation and the choice of the form of involvement is considered to constitute an obligation of researchers and decision makers early in the process. Involvement should take place on a fair basis. Decision makers should consider determining specific requirements for patient orientation, e. g. in their calls for proposals or selection/award criteria.
本文从患者的角度探讨了医学研究中以患者为导向及患者参与方面存在的不足,并为其进一步发展提供了建议。研究人员常常以一种无组织、不一致的方式践行以患者为导向及患者参与。患者是否参与以及如何参与的决策在很大程度上是研究人员的责任。这一决策应始终是研究项目以患者为导向调整的一部分,无论患者组织是否存在、主动参与,研究人员都应追求这一点。可能的参与模式被分配到研究过程的不同阶段。在本文中,以患者为导向及参与形式的选择被视为研究人员和决策者在过程早期的一项义务。参与应在公平的基础上进行。决策者应考虑确定以患者为导向的具体要求,例如在他们的招标书或选择/奖励标准中。